Can Aliskiren "COMPLEMENT" our management of kidney disease?
作者信息
Pramod Sheena, Mustafa Bisher O, Khitan Zeid J
机构信息
Internal Medicine Department, Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia.
出版信息
J Clin Hypertens (Greenwich). 2019 May;21(5):687-688. doi: 10.1111/jch.13524. Epub 2019 Mar 26.
Abstract
摘要
相似文献
1
Can Aliskiren "COMPLEMENT" our management of kidney disease?阿利吉仑能否“补充”我们对肾脏疾病的治疗？
J Clin Hypertens (Greenwich). 2019 May;21(5):687-688. doi: 10.1111/jch.13524. Epub 2019 Mar 26.
2
Aliskiren inhibits renin-mediated complement activation.阿利吉仑抑制肾素介导的补体激活。
Kidney Int. 2018 Oct;94(4):689-700. doi: 10.1016/j.kint.2018.04.004. Epub 2018 Jun 5.
3
Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.肾素抑制通过改变促纤维化和抗纤维化因子之间的平衡逆转转基因小鼠的肾脏疾病。
Hypertension. 2013 Apr;61(4):901-7. doi: 10.1161/HYPERTENSIONAHA.111.00639. Epub 2013 Feb 25.
4
Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.阿利吉仑，首个直接肾素抑制剂：评估其在儿童高血压和肾脏疾病中的作用。
Pediatr Nephrol. 2014 Nov;29(11):2105-11. doi: 10.1007/s00467-013-2716-0. Epub 2013 Dec 14.
5
Renoprotection by Direct Renin Inhibition: A Systematic Review and Meta- Analysis.直接肾素抑制的肾保护作用：系统评价和荟萃分析。
Curr Vasc Pharmacol. 2018 Jan 26;16(2):157-167. doi: 10.2174/1570161115666170502104809.
6
[Aliskiren hemifumarate].
Dtsch Med Wochenschr. 2008 Jun;133(24):1308-12. doi: 10.1055/s-2008-1077232. Epub 2008 May 9.
7
[Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].[直接肾素抑制剂阿利吉仑在心血管和肾脏疾病治疗中的应用]
Vnitr Lek. 2010 Feb;56(2):120-6.
8
A novel role of renin inhibitor in the complement cascade.肾素抑制剂在补体级联反应中的新作用。
Kidney Int. 2018 Oct;94(4):650-652. doi: 10.1016/j.kint.2018.05.025.
9
New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.新型血管紧张素原抑制剂阿利克仑在实验性肾病中的肾脏保护作用的新见解。
Hypertens Res. 2010 Apr;33(4):279-87. doi: 10.1038/hr.2010.19. Epub 2010 Mar 5.
10
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.在高盐负荷的人肾素血管紧张素原转基因小鼠中，肾素抑制通过显著抑制血管紧张素I和II来改善肾损伤。
Clin Exp Nephrol. 2014 Aug;18(4):593-9. doi: 10.1007/s10157-013-0893-6. Epub 2013 Oct 24.
本文引用的文献
1
Aliskiren inhibits renin-mediated complement activation.阿利吉仑抑制肾素介导的补体激活。
Kidney Int. 2018 Oct;94(4):689-700. doi: 10.1016/j.kint.2018.04.004. Epub 2018 Jun 5.
2
All Things Complement.补体的一切
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1856-1866. doi: 10.2215/CJN.01710216. Epub 2016 Jun 23.
3
New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulness of the direct renin inhibitor aliskiren.阻断肾素-血管紧张素-醛固酮系统的新方法：直接肾素抑制剂阿利克仑的特点和用途。
J Pharmacol Sci. 2010;113(4):296-300. doi: 10.1254/jphs.10r04fm. Epub 2010 Jul 27.
4
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes.2型糖尿病中直接肾素抑制的抗蛋白尿和降压作用的时间进程。
Kidney Int. 2008 Jun;73(12):1419-25. doi: 10.1038/ki.2008.68. Epub 2008 Mar 12.
5
Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats.阿利吉仑是一种新型肾素抑制剂，在大鼠晚期糖尿病肾病模型中具有肾脏保护作用。
Diabetologia. 2007 Nov;50(11):2398-404. doi: 10.1007/s00125-007-0795-9. Epub 2007 Sep 8.
6
Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.健康志愿者中直接肾素抑制剂阿利吉仑的吸收、分布、代谢及排泄
Drug Metab Dispos. 2007 Aug;35(8):1418-28. doi: 10.1124/dmd.106.013797. Epub 2007 May 17.
7
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.阿利吉仑是一种新型口服有效的肾素抑制剂，可降低狨猴和自发性高血压大鼠的血压。
J Hypertens. 2005 Feb;23(2):417-26. doi: 10.1097/00004872-200502000-00025.
Zotero 插件